2013 № 11 Methodology of calculating industrial registration indicators, diagnostics and efficiency of medical treatment for patients suffering from tuberculosis (Federal Public Health Institute for Health Care Organization and Information of the Ministry of Public Health of Russian Federation, Moscow, Russia)
There are announced the principal mechanisms affecting the size of registration indicators, diagnostics and treatment efficiency for patients suffering from tuberculosis. There are presented the consequences of a number of management solutions.
2016 № 4 The analysis of the experience of the organization of treatment of TB patients under the program «hospital at home»
Annotation. The new organizational model of treatment of TB patients – hospital at home was developed and introduced with the purpose to increase efficiency of TB patients’ treatment. We defined indicators for patients’ referral to the «hospital at home». It was proved that the directly observed treatment in a «hospital at home» has high efficiency and low frequency of treatment defaults: completed effectively the course of chemotherapy 90.7% of patients, ineffectively – 2.0%, interrupted treatment – 3.5%, departed – 0.3%, transferred to in-patient departments – 3.5%.
Pharmacoeconomic analysis showed that treatment cost at a «hospital at home» is 2.5 times lower than that for treating patients in an in-patient department and 1.6 times lower than that in an in-patient department for MDR-TB patients.
2017 № 8 The Results of a study of financing of TB control activities
Tuberculosis control in the Russian Federation has a high national priority, confirmed a high level of funding for TB activities. The value of the costs per patient of tuberculosis is the highest in the world. The main economic burden of TB falls on the budgets of the constituent entities of the Russian Federation. The article presents the results of the analysis of volumes of financing on the main financial sources and areas of spending of budget funds for TB care in 2015. Presents cross-country comparative analysis of the financing of TB control in countries with high burdens of tuberculosis and tuberculosis, caused by the pathogen with multidrug resistance. The dynamics of the state of basic funds of TB of the medical organizations and the calculations of the financial requirements for their updating